Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
William DiStefano, lung cancer survivor, and Thomas L. Bauer, MD, Thoracic and Cardiac Surgery, Hackensack Meridian Health, Jersey Shore University Medical Center, discuss the considerations and benefits of…
Terence T. Sio, MD, MS, associate professor of radiation oncology at the Mayo Clinic and specialist in both X-ray-based and proton radiotherapies, discusses study results comparing the efficacy…
Long-term data from the KEYNOTE-010 trial showed that 35% of over 1,000 patients with non-small cell lung cancer (NSCLC) who had progressed on chemotherapy and were then treated…
New study data suggests that patients with metastatic melanoma are able to receive long term benefit after only receiving treatment for a limited time. The study aimed to…
The Oncologic Drugs Advisory Committee (ODAC) voted 6–5 that combining ramucirumab combined with established first-line EGFR-directed therapy had a favorable risk-benefit profile for patients with metastatic EGFR-mutant non-small…
Recent advances in digital surveillance for melanoma monitoring and treatment have been encouraging to Tracey Liebman, MD. Dermoscopic monitoring through sequential digital dermoscopy imaging can be used to…
Advances in surgical treatments of melanoma have changed how surgeons treat patients with melanoma. According to Richard L. Shapiro, MD, associate professor in the Department of Surgery at…
Christopher Hourigan, MD, PhD, associate professor at Johns Hopkins and principal investigator at the National Heart, Lung, and Blood Institute of the National Institutes of Health, highlights his…
In this double interview, Ross Camidge, MD, PhD, of the University of Colorado Cancer Center, and Lyudmila A. Bazhenova, MD, of UC San Diego Health, provide insights into…
New techniques and technology advancements in the field of radiation oncology are the topics of discussion in this interview with Amin J. Mirhadi, MD, associate professor of radiation…
